Premium
Methylprednisolone added to tocilizumab reduces mortality in SARS‐CoV‐2 pneumonia: An observational study
Author(s) -
Sanz Herrero F.,
Puchades Gimeno F.,
Ortega García P.,
Ferrer Gómez C.,
Ocete Mochón M. D.,
García Deltoro M.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13145
Subject(s) - medicine , tocilizumab , methylprednisolone , observational study , pneumonia , covid-19 , betacoronavirus , intensive care medicine , virology , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom